                         SEQUENCE LISTING

<110>  TargImmune Therapeutics AG
 
<120>  IMMUNOTHERAPY FOR THE TREATMENT OF CANCER

<130>  P5730PC00

<150>  EP19167141.1
<151>  2019-04-03

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  79
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  1

Met Gly Ser Ser His His His His His His Ser Ser Gly Leu Val Pro 
1               5                   10                  15      


Arg Gly Ser His Met Ala Glu Ala Lys Tyr Ala Lys Met Arg Asn Ala 
            20                  25                  30          


Tyr Trp Glu Ile Ala Leu Leu Pro Asn Leu Thr Asn Gln Gln Lys Arg 
        35                  40                  45              


Ala Phe Ile Arg Lys Leu Tyr Asp Asp Pro Ser Gln Ser Ser Glu Leu 
    50                  55                  60                  


Leu Ser Glu Ala Lys Lys Leu Asn Asp Ser Gln Ala Pro Lys Cys 
65                  70                  75                  


<210>  2
<211>  53
<212>  PRT
<213>  Homo sapiens

<400>  2

Asn Ser Asp Ser Glu Cys Pro Leu Ser His Asp Gly Tyr Cys Leu His 
1               5                   10                  15      


Asp Gly Val Cys Met Tyr Ile Glu Ala Leu Asp Lys Tyr Ala Cys Asn 
            20                  25                  30          


Cys Val Val Gly Tyr Ile Gly Glu Arg Cys Gln Tyr Arg Asp Leu Lys 
        35                  40                  45              


Trp Trp Glu Leu Arg 
    50              


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is 8-aminooctanoic acid.

<400>  3

Xaa Phe Gly Trp Trp Gly Cys 
1               5           


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X is 8-aminooctanoic acid

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  X is diaminopropionic acid

<400>  4

Xaa Phe Phe Xaa Asp Cys 
1               5       


